Ilika to showcase Stereax batteries to medical device manufacturers

Ilika Plc

Ilika’s Stereax solid state batteries will be represented at Medical Technology Ireland 2026, giving the company direct exposure to medical device manufacturers, suppliers and engineers.

The event takes place at Galway Racecourse on 23rd and 24th September 2026 and is focused on medical device design and manufacturing. Ilika is continuing to put its miniature battery technology in front of a market where small, reliable power sources are highly relevant.

Stereax batteries are designed for compact applications, including medical devices. In this market, battery size, reliability and ease of integration can be important factors when companies are developing next-generation products. Ilika’s presence at the event, through Cirtec Medical, helps keep the technology visible to the people involved in designing and producing those devices.

Product development cycles can be long, and customers typically need confidence in performance, manufacturing quality and supply before adopting new components. Regular engagement with the sector helps Ilika stay connected to potential customers and partners while the market continues to assess suitable battery solutions.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Defence battery demand highlights strategic opening for Ilika

Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.

Ilika to showcase Stereax batteries to medical device manufacturers

Ilika’s Stereax batteries will be represented at Medical Technology Ireland 2026, giving the company direct exposure to medical device manufacturers and suppliers.

Search